PEER evaluation of EEGs??.

I do not know what this PEER is about!!?., but they claim that a EEG evaluation software developed by physicians to address what type of drug treatment regiment can be appropriate for certain mental illness??. I have no idea about what this method or test is about, and I have nothing to say as far as it validity and clinical usefulness, since it is related to neuroscience and monitoring related area, I thought to post it here.

CNS Response Details Response to FDA Feedback on Investigational Device

Company plans to design revised protocol and launch a clinical trial with the Walter Reed National Military Medical Center.

Scottsdale, AZ (PRWEB) March 25, 2012

QualityStocks would like to highlight CNS Response, a publicly traded company providing reference data and analytic tools for clinicians and researchers in psychiatry.

The company offers an online registry, developed by physicians, that enables qualified medical professionals to exchange objective, statistical neurophysiology-based data on individual patient medication response and outcomes.

In the company’s news last week,
CNS Response announced that the U.S. Food and Drug Administration (FDA) has responded to the company’s proposal for a clinical trial of an investigational device, PEER Interactive, designed to help physicians identify the best treatments for certain mental illnesses.
PEER Interactive, a Web service based on a standard electroencephalogram (EEG), records a patient’s brain function much like an electrocardiogram (EKG) does for the heart. The Psychiatric EEG Evaluation Registry (PEER) was developed by physicians as a quality assurance tool to determine which psychiatric medications are effective and which are not.

NeuroMonitoring News!

Clinic Meditex Opens Neurophysiology Service in Angola (Neurophysiology in Cuba?)

December 7, 2010

Summary: 

12/06/2010. Meditex medical clinic, where Cuban collaborators 
are working, opened on Monday a new neurophysiology service, 
with high technology equipment produced by the
Center for Neurosciences of Cuba.

SEDLine™ Announces Acquisition of Hospira 

Brain Function

SEDLine™ Announces Acquisition of Hospira 
Brain Function Monitoring Business: 
 New company formed to advance 
neuromonitoring technologies to 
improve the care of patients under
anesthesia or sedation

*******************Business Wire*****************
IRVINE, Calif. -- January 12, 2010
SEDLine™, Inc., announced today that it has 

acquired the brain functionmonitoring business of 

Hospira, Inc. (NYSE:HSP). Privately held and

 backedwith an investment from Masimo

 Corporation (NASDAQ:MASI), SEDLine, 

Inc., basedin Irvine, California, was formed

 with the mission to advance neuromonitoringtechnologies

 to improve the care of patients under anesthesia 

or sedation

FDA Approves Bryan Cervical Disc for Radicular, 

Intractable Neck or Arm Pain 

Laurie Barclay, MDAuthors and Disclosures Information 

from Industry Evidence from the GAIT studyshows a compelling

 risk-benefit ratio for nutraceuticals with glucosamine and

chondroitin.Learn more from an Expert Interview with 

David Hungerford, MDJune 3, 2009 — On May 12, 

the US Food and Drug Administration (FDA) approved 

the Bryan Cervical Disc (Medtronic; Memphis, Tennessee)

 for replacement of diseased or bulging cervical disc at the

 C3 to C7 level that is causing radicular, intractable neck or arm pain.

This device is constructed of 2 primary titanium pieces separated by a polyurethane part. After surgical removal of the diseased disc, the new cervical disc device is positioned in milled pockets in the adjacent vertebral bodies.The approved indication for use is to replace a cervical disc from C3 to C7 once it is removed in patients who have failed at least 6 weeks of conservative therapy for intractable radiculopathy and/or myelopathy secondary to disc degeneration or herniation. Anticipated outcomes from device implantation include pain relief and improved function.

Like a spinal fusion procedure, this device is intended to improve postoperative stability of the operated cervical level. Unlike conventional spinal fusion, however, the cervical disc device is intended to allow motion at the operated spinal level.
Medtronic launches intraoperative nerve integrity monitors for surgeons

9 October 2009

Medtronic (NYSE: MDT) has launched the NIM-Response 3.0 and NIM-Neuro 3.0 intraoperative nerve integrity monitors designed for a variety of surgeons, including ear, nose, and throat (ENT); endocrine; general; and peripheral surgeons.

During minimally invasive or traditional open surgery, Medtronic’s Nerve Integrity Monitor (NIM) systems enable surgeons to identify and confirm motor nerve function and monitor major motor nerves throughout the body, such as cranial nerves in a patient’s head, face and neck.